2025 POSTER PRESENTATIONS

P01: Validation of a Cancer Early-Detection Assay on Liquid Biopsies Using DNA Methylation, Presented by Marci N., Diagenode, a Hologic company

P02: Multiomic Liquid Biopsy Platform Powered by Infrared Spectroscopy and AI, Presented by Holly B., Dxcover

P03: Fecal HBA mRNA as an Alternative to the Protein-Based FIT Assay for Colorectal Cancer Screening, Presented by Wenying P., El Capitan Biosciences, Inc.

P04: SAMRS Primers: Unlocking Robust Multiplexing in <10 Minute PCR, Presented by Luran M., Foundation for Applied Molecular Evolution

P05: Self-Avoiding Molecular Recognition Systems (SAMRS) Empower Highly Flexible Multiplexed RT-PCR Assays, Presented by Zunyi Y., Foundation for Applied Molecular Evolution

P06: Integrated Multimodal and AI-Driven Platforms for Infectious Diseases: From Rapid Pathogen Detection to Antimicrobial Susceptibility Testing, Presented by Aida E., Pennsylvania State University

P07: Dual Probe-Based Method for Mutation Detection Using Isothermal Amplification, Presented by Michael M., Revvity

P08: SeekIt™ for Mycobacterium Tuberculosis: User-Friendly, Accurate, Equipment-Free, Molecular Diagnostic for Tuberculosis at the Point-of-Care, Presented by Annie R., Seek Labs

P09: Balancing High NPV and Insufficient PPV: Results of a Pilot Cancer Screening Study Using the CA-62 Biomarker, with Applicability to Its Commercial Use, Presented by Evgueni K., UCM Technologies, Inc.

P10: CA125 Glycovariant Assays Improve the Accuracy of Ovarian Cancer Detection, Presented by Leena K., Uniogen Oy

P11: RapiSep: A Plasma Separator Enabling Remote Blood Tests, Presented by Meng S., Zymeron Corporation